Divalent Ion Metabolism

  • Jack W. Coburn
  • Kiyoshi Kurokawa
  • Charles R. Kleeman


The thrust of this review is directed to certain specific topics of divalent ion metabolism, rather than to providing a tedious, “index card” description of all topics related to divalent ion metabolism. Research and clinical studies in the field of altered vitamin D metabolism are appearing with great frequency with more investigators now involved. Thus, the focus of this review includes recent advances in the metabolism and actions of vitamin D, a discussion of clinical disorders that are believed to relate to altered vitamin D metabolism or action, the regulation of phosphate homeostasis, and a more recent update on the syndrome of phosphate depletion. Hyperparathyroidism and hypercalcemia are not included in this review; the reader may find such a review in Contemporary Endocrinology, Vol. 1 (Kleeman and Kleeman, 1979). Limiting the review to these few topics made possible a more cohesive text.


Nephrotic Syndrome Primary Biliary Cirrhosis Parathyroid Gland Unilateral Ureteral Obstruction Other Hand 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aitken, J. M., Hart, D. M., and Smith, D. A., 1971, The effect of long term mestranol administration on calcium and phosphorus homeostasis in oopho- rectomized women, Clin. Sei. 41: 233–236.Google Scholar
  2. Ando, M., Sayato, Y., Tonomura, M., and Osawa, T., 1977, Studies on excretion and uptake of calcium by rats after continuous oral administration of cadmium, Toxicol Appl. Pharmacol. 39: 321–327.PubMedCrossRefGoogle Scholar
  3. Arnaud, S. B., Matthusen, M., Gükinson, J. B., and Goldsmith, R. S., 1977, Components of 25–hydroxy-vitamin D in serum of young children in upper midwestern United States, Am. J. Clin. Nutr. 30: 1082–1086.Google Scholar
  4. Aschinberg, L. C., Solomon, L. M., Zeis, P. M., Justice, P., and Rosenthal, I. M., 1977, Vitamin D-resistant rickets associated with epidermal nevus syndrome: Demonstration of a phosphaturic substance in the dermal lesions, J. Pediatr. 91: 56–60.Google Scholar
  5. Balsan, S., Garabedian, M., Sogniard, R., Holick, M. F., and DeLuca, H. F., 1975, 1,25–Dihydroxy-vitamin Dg and la-hydroxy-vitamin Dg in children: Biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance, Pediatr. Res. 9: 586–593.Google Scholar
  6. Barragry, J. M., France, M. W., Carter, N. D., Auton, J. A., Beer, M., Boucher, B. J., and Cohen, R. D., 1977, Vitamin D metabolism in nephrotic syndrome. Lancet 2: 629–632.PubMedCrossRefGoogle Scholar
  7. Baumann, K., de Rouffignac, C., Roinel, N., Rumrich, G., and Ullrich, K.J., 1975, Renal phosphate transport: Inhomogeneity of local-proximal transport rates and sodium dependence, Pfluegers Arch. 356: 287–298.Google Scholar
  8. Baylink, D. J., 1977, Effect of phosphate depletion on bone. Proceedings of the 3rd International Phosphate Workshop, Madrid, Spain.Google Scholar
  9. Baylink, D. J., Wergedal, J., and Stauffer, M., 1971, Formation, mineralization and resorption of bone in hypophosphatemic rats,J. Clin. Invest. 50: 2519–2530.CrossRefGoogle Scholar
  10. Bickle, D. D., and Rasmussen, H., 1975, The ionic control of 1,25–dihydroxy- vitamin D3 production in isolated chick renal tubules,J. Clin. Invest. 55: 292–298.CrossRefGoogle Scholar
  11. Bijvoet, O. L. M., 1969, Relation of plasma phosphate concentration to renal tubular reabsorption of phosphate, Clin. Sei. 37: 23–36.Google Scholar
  12. Bonjour, J. P., Preston, C., and Fleisch, H., 1977, Effects of 1,25–dihydroxy- vitamin D3 on the renal handling of Pi in thyroparathyroidectomized rats, J. CUn. Invest. 60: 1419–1428.CrossRefGoogle Scholar
  13. Booth, B. E., Tsai, H. C., and Morris, R. C., Jr., 1977, Metabolic acidosis in the vitamin D-deficient chick. Metabolism 26: 1099–1105.PubMedCrossRefGoogle Scholar
  14. Bordier, P., Ryckwaert, A., Marie, P., Mira vet, L., Norman, A. W., and Rasmussen, H., 1977, Vitamin D metabolites and bone mineralization in man, in: Vitamin D: Biochemical, Chemical and Clinical Aspects Related to Calcium Metabolism ( A. W. Norman, K. Schaefer, J. W. Coburn, H. F. DeLuca, D. Eraser, H. G. Grigo- leit, and D. v. Herrath, eds.), pp. 897–911, Walter de Gruyter, Berlin and New York.Google Scholar
  15. Bouillon, R., van Baelen, H., and de Moor, P., 1977, 25–Hydroxy-vitamin D and its binding protein in maternal and cord serum, J. Clin. Endocrinol Metab. 45: 679–684.CrossRefGoogle Scholar
  16. Boyle, 1. T., Omdahl, J. L., Gray, R. W., and DeLuca, H. F., 1973, The biological activity and metabolism of 24,25–dihydroxy-vitamin Dg, J. Biol Chem. 248: 4174–4180.Google Scholar
  17. Brenton, D. P., Dent, C. E., and Gertner, J. M., 1977, The treatment of hypoparathyroidism with la-hydroxycholecalciferol, Calcif. Tissue Res. 22 (Suppl.): 545–552.Google Scholar
  18. Brewer, E. D., Tsai, H. C., Szeto, K. S., and Morris, R. C., Jr., 1977a, Maleic acid- induced impaired conversion of 25(OH)D3 to l,25(OH)2D3; Implication for Fanconi’s syndrome. Kidney Int. 12: 244–252.Google Scholar
  19. Brewer, E. D., Tsai, H. C., and Morris, R. C., 1977b, Fanconi syndrome and its relationship to vitamin D, in: Vitamin D: Biochemical, Chemical and Clinical Aspects Related to Calcium Metabolism ( A. W. Norman, K. Schaefer, J. W. Coburn, T. F. DeLuca, D. Eraser, H. G. Grigoleit, and D. v. Herrath, eds.), pp. 937–949, Walter de Gruyter, Beriin and New York.Google Scholar
  20. Brickman, A. S., Hartenbower, D. L., Norman, A. W., and Coburn, J. W., 1977, Actions of la-hydroxy-vitamin D3 and la,25–dihydroxy-vitamin D3 on mineral metabolism in man. I. Effects on net absorption of phosphorus. Am. J. Clin.Nutr. 30: 1064–1069.Google Scholar
  21. Brumbaugh, P. F., Hughes, M. R., and Haussler, M. R., 1975, Cytoplasmic and nuclear binding components for la,25–dihydroxy-vitamin Dg in chick parathyroid glands, Proc. Natl Acad. Sci. U.S.A. 72: 4871–4875.CrossRefGoogle Scholar
  22. Care, A. D., Bates, R. F. L., Pickard, D. W., Peacock, M., Tomlinson, S., Riordan, J. L. H., Mawer, E. B., Tailor, C. M., DeLuca, H. F., and Norman, A. W., 1977, The effects of vitamin D metabolites and their analogues on the secretion of parathyroid hormone, Calcif. Tissue Res. 21 (Suppl.): 142–146.Google Scholar
  23. Chaimovitz, C., Dickmeyer, J., Friedler, R. M., Kurokawa, K., and Massry, S. G., 1977, Studies on mechanism of hypophosphaturia after relief of unilateral ureteral obstruction. Nephron 19: 333–341.PubMedCrossRefGoogle Scholar
  24. Chertow, B. S., Baylink, D. J., Wergedal, J. E., Su, M. H. H., and Norman, A. W., 1975, Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25–dihydroxycholecalciferol, Clin. Invest. 56: 668–678.CrossRefGoogle Scholar
  25. Clark, M. B., and Potts, J. T., Jr., 1977, 25–Hydroxy-vitamin Dg, Calcif. Tissue Res. 22(Suppl.):29 -34.Google Scholar
  26. Cloix, J. G., Ulmann, A., Bachelet, M., and Funck-Bretano, 1976, Cholecalciferol metabolites binding in porcine parathyroid glands. Steroids 28: 743–749.PubMedCrossRefGoogle Scholar
  27. Coburn, J. W., and Hartenbower, D. L., 1977, Physiology of calcium, phosphorus and magnesium and disorders affecting their metabolism, in: Current Nephrology ( H. C. Gonick, ed.). Vol. I, pp. 99–171, Pinecliff Medical Publishing Co., Pacific Palisades, California.Google Scholar
  28. Coburn, J. W., Brickman, A. S., Sherrard, D. J., Singer, F. R., Baylink, D. J., Wong, E. G. C., Massry, S. G., and Norman, A. W., 1977, Clinical efficacy of 1,25–dihydroxy-vitamin Dg in renal osteodystrophy, in: Vitamin D: Biochemical, Chemical and Clinical Aspects Related to Calcium Metabolism ( A. W. Norman, K. Schaefer, J. W. Coburn, H. F. DeLuca, D. Eraser, H. G. Grigoleit, and D. v. Herrath, eds.), pp. 657–666, Walter de Gruyter, Berlin and New York.Google Scholar
  29. Coburn, J. W., Hartenbower, D. L., and KJeeman, C. R., 1978, Divalent ion metabolism, in: The Year in Metabolism 1977 ( N. Freinkel, ed.), pp. 327–377, Plenum Medical Book Company, New York and London.Google Scholar
  30. Coe, F. L., Firpo, J. J., Hollandsworth, D. L., Segil, L., Canterbury, J. M., and Reiss, E. M., 1975, Effect of acute and chronic metabolic acidosis on serum immunoreactive parathyroid hormone in man, Kidney Int. 8: 262–273.CrossRefGoogle Scholar
  31. Colston, K. W., Evans, I. M. A., Spelsberg, T. C., and Maclntyre, I., 1977, Feedback regulation of vitamin D metabolism by 1,25–dihydroxycholecalci- ierol, Biochem. J. 164: 83–89.PubMedGoogle Scholar
  32. Compston, J. E., and Thompson, R. P., 1977, Intestinal absorption of 25–hydroxy- vitamin D and osteomalacia in primary biliary cirrhosis. Lancet 1: 721–726.PubMedCrossRefGoogle Scholar
  33. Corvilain, J., Abramow, M., and Bergans, A., 1964, Effect of growth hormone on tubular transport of phosphate in normal and parathyroidectomized dogs,J. Clin. Invest. 43: 1608–1612.CrossRefGoogle Scholar
  34. Cuisinier-Gleizes, P., Thomasset, M., and Mathieu, H., 1976a, Homeostasis of P and Ca in phosphorus deprivation, in: Phosphate Metabolism, Kidney and Bone ( L. Avioli, Ph. Bordier, H. Fleisch, S. Massry, and E. Slatopolsky, eds.), pp. 381–386, Nouvelle Imprimerie Fournie, Toulouse.Google Scholar
  35. Cuisinier-Gleizes, P., Thomasset, M., Sainteny-Debove, F., and Mathieu, H., 1976b, Phosphorus deficiency, parathyroid hormone, and bone resorption in the growing rat, Calcif. Tissue Res. 20: 235–249.CrossRefGoogle Scholar
  36. Davies, M., 1977, Effects of 1,25–dihydroxycholecalciferol on calcium and phosphorus metabolism in hypoparathyroidism, Calcif. Tissue Res. 22 (Suppl.): 68–73.Google Scholar
  37. DeLuca, H. F., 1977, Vitamin D endocrine system, Adv. Clin. Chem. 19: 125–174.CrossRefGoogle Scholar
  38. Dennis, V. W., Bello-Reuss, E., and Robinson, R. R., 1977, Response of phosphate transport to parathyroid hormone in segments of rabbit nephron. Am. J. Physiol. 233: F29–F38.PubMedGoogle Scholar
  39. DeRouffignac, C., Morel, F., Moss, N., and Roinel, N., 1973, Micropuncture study of water and electrolyte movements along the loop of Henle in psammomys with special reference to magnesium, calcium and phosphorus, Pflu£gers Arch. 344: 309–326.CrossRefGoogle Scholar
  40. Doxiadis, S. A., and Lapatsants, P. D., 1977, la-Hydroxy-vitamin D in neonatal hypocalcaemia (letter), Lancet 1: 426.Google Scholar
  41. Drezner, M. K., and Feinglos, M. N., 1977, Osteomalacia due to la,25–dihydroxy- cholecalciferol deficiency,J. Clin. Invest. 60: 1046–1053.CrossRefGoogle Scholar
  42. Drezner, M. K., Neelon, F. A., Jowsey, J., and Lebovitz, H. E., 1977, Hypoparathy-roidism: A possible cause of osteomalacia,J. Clin. Endocrinol. Metab. 45: 114–122.CrossRefGoogle Scholar
  43. Eastwood, J. B., Stamp, T. C. B., De Wardener, H. E., Bordier, P. J., and Arnaud, C. D., 1977, The effect of 25–hydroxy-vitamin Dg in osteomalacia of chronic renal faüure, Clin. Sei. Mol. Med. 52: 499–508.Google Scholar
  44. Eisenberg, E., 1965, Effects of serum calcium level in parathyroid extracts on phosphate and calcium excretion in hypoparathyroid patients,J. Clin. Invest. 44: 942–946.Google Scholar
  45. Emmett, M., Goldfarb, S., Agus, Z. S., and Narins, R. G., 1977, The pathophysiology of acid-base changes in chronically phosphate-depleted rats, J. Clin. Invest. 59: 291–298.CrossRefGoogle Scholar
  46. Fairney, A., Naughten, E., and Oppe, T. E., 1977, Vitamin D and human lactation, Lancet 2: 739–741.PubMedCrossRefGoogle Scholar
  47. Favus, M. J., Rimberg, D. V., MiUar, G. N., and Gersham, E., 1973a, Effects of cortisone administration on the metabolism and localization of 25–hydroxy- cholecalciferol in the rat,J. Clin. Invest. 52: 1328–1335.CrossRefGoogle Scholar
  48. Favus, M. J., Walling, M. W., and Rimberg, D. V., 1973b, Effect of 1,25–dihy- droxycholecalciferol on intestinal calcium transport in cortisone-treated rats, J. Clin. Invest. 52: 1680–1686.CrossRefGoogle Scholar
  49. Fournier, A. E., Bordier, P. J., Gueris, J., Chanard, J., Marie, P., Ferriere, C., Osario, M., Bedrossian, J., and DeLuca, H. F., 1976, 1 a-Hydroxycholecalci- ferol in renal bone disease, Proc. Eur. Dial. Transplant Assoc. 12: 227–236.Google Scholar
  50. Fraser, D., and Scriver, C. R., 1976, Familial forms of vitamin D-resistant rickets revisited: X-linked hypophosphatemia and autosomal recessive vitamin D dependency, Am. J. Clin. Nutr. 29: 1315–1329.Google Scholar
  51. Frymoyer, J. W., and Hodgkin, W., 1977, Adult-onset vitamin D-resistant hypo- phosphatemic osteomalacia: A possible variant of vitamin D-resistant rickets, J. Bon£ Joint Surg. 59A: 101–106.Google Scholar
  52. Gerblich, A. A., Genuth, S. M., and Haddad, J. F., 1977, A case of idiopathic hypoparathyroidism and dietary vitamin D deficiency: The requirement for calcium and vitamin D for bone, but not renal responsiveness to PTH,J. Clin. Endocrinol. Metab. 44: 507–513.CrossRefGoogle Scholar
  53. Gold, L. W., Massry, S. G., Arieff, A. I., and Coburn, J. W., 1973, Renal bicarbonate wasting during phosphate depletion: A possible cause of altered acid- base homeostasis in hyperparathyroidism, J. Clin. Invest. 52: 2556–2562.Google Scholar
  54. Goldfarb, S., Westby, G. R., Goldberg, M., and Agus, Z. S., 1977, Renal tubular effects of chronic phosphate depletion,J. Clin. Invest. 59: 770–779.CrossRefGoogle Scholar
  55. Goldstein, D. A., Oda, Y., Rurokawa, R., and Massry, S. G., 1977, Blood levels of 25–hydroxy-vitamin D in nephrotic syndrome: Studies in 26 patients, Ann. Intern. Med. 87: 664–667.Google Scholar
  56. Haddad, J. G., Jr., and Walgate, J., 1976, Radioimmunoassay of the binding protein for vitamin D and its metabolites in human serum, J. Clin. Invest. 58: 1217–1222.CrossRefGoogle Scholar
  57. Haddad, J. G., Min, G., Mendelsohn, M., Slatopolsky, E., and Hahn, T. J., 1977, Competitive protein-binding radioassay of 24,25–dihydroxy-vitamin D in sera from norm and anephric subjects, Arch. Biochem. Biophys. 182: 390–395.CrossRefGoogle Scholar
  58. Hahn, T. J., Halstead, L. R., Scharp, G. R., and HaHc, B. H., 1976, Mineral metabolism and response to 25–hydroxyvitamin D therapy in patients with steroid induced osteopenia, Endocrine Soc. Annu. Meeting 58: 62.Google Scholar
  59. Hahn, T. J., Halstead, L. R., and Haddad, J. G., 1977, Serum 25–hydroxy-vitamin D concentrations in patients receiving chronic corticosteroid therapy, J. Lab. Clin. Med. 90: 399–404.Google Scholar
  60. Harrison, H. G., and Harrison, H. E., 1976, Inhibition of vitamin D-stimulated active transport of calcium of rat intestine by diphenylhydantoin-phenobar- bital treatment, Proc. Soc. Exp. Biol. Med. 153: 220–224.Google Scholar
  61. Haussler, M. R., and McCain, T. A., 1977, Basic and clinical concepts related to vitamin D metabohsm and action, N. Engl. J. Med. 297:974–983 and 1041–1050.Google Scholar
  62. Haussler, M. R., Hughes, M. R., McCain, T. A., Zerwekh, Z. E., Brumbaugh, P. F., Jubiz, W., and Wasserman, R. H., 1977, 1,25–Dihydroxy-vitamin D3: Mode of action in intestine and parathyroid glands, assays in humans and isolation of its glycoside from Solarium malacoxylon, Calcif. Tissue Res. 22(Suppl.): 1–18.Google Scholar
  63. Henry, H. L., Taylor, A. N., and Norman, A. W., 1977, Response of chick parathyroid glands to the vitamin D metabolites, 1,25–dihydroxycholecalci- ferol and 24,25–dihydroxycholecalciferol,Nutr. 107: 1918–1926.Google Scholar
  64. Holick, M. F., Kleiner-Bossaler, A., Schnoes, H. K., Kasten, P. M., Boyle, I. T., and DeLuca, H. F., 1973, 1,24,25–Trihydroxy-vitamin Dg: A metabolite of vitamin D3 effective on intestine,J. Biol Chem. 248: 6691–6696.Google Scholar
  65. Holick, M. F., Baxter, L. A., Schrautrogel, P. K., Tavela, T. E., and DeLuca, H. F., 1976, Metabolism and biological activity of 24,25–dihydroxy-vitamin D3 in the chick, J. Biol Chem. 251: 397–402.PubMedGoogle Scholar
  66. Horiuchi, N., Suda, T., Takahashi, H., Shimazawa, E., and Ogata, E., 1977, In vivo evidence for the intermediary role of 3’,5’-cyclic AMP in parathyroid hormone-induced stimulation of 1 a,25–dihydroxy-vitamin D3 synthesis in rats. Endocrinology 101: 969–974.PubMedCrossRefGoogle Scholar
  67. Imawari, M., and Goodman, D. S., 1977, Immunological and immunoassay studies of the binding protein for vitamin D and its metabolites in human serum, J. Clin. Invest 59: 432–442.CrossRefGoogle Scholar
  68. Jubiz, W., Haussler, M. R., McCain, T. A., and Tolman, K. G., 1977, Plasma 1,25–dihydroxy-vitamin D levels in patients receiving anticonvulsant drugs,J. Clin. Endocrinol Metab. 44: 617–621.CrossRefGoogle Scholar
  69. Kanis, J. A., and Russell, R. G. G., 1977, Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its la-hydroxylated derivatives, Br. Med. J. 1: 78–81.PubMedCrossRefGoogle Scholar
  70. Kanis, J. A., Heynen, G., Russell, R. G. G., Smith, R., Walton, R. J., and Warner, G. T., 1977, Biological effects of 24,25–dihydroxycholecalciferol in man, in: Vitamin D: Biochemical, Chemical and Clinical Aspects Related to Calcium Metabolism ( A. W. Norman, K. Schaefer, J. W. Goburn, H. F. DeLuca, D. Eraser, H. G. Grigoleit, and D. v. Herrath), pp. 793–795, Walter de Gruyter, Berlin and New York.Google Scholar
  71. Kleeman, K., and Kleeman, C. R., 1979, Parathyroid hormone, in: Contemporary Endocrinology, Vol. 1 ( S. Ingbar, ed.), pp. 305–339, Plenum Medical Book Company, New York.Google Scholar
  72. Klein, R. G., Arnaud, S. B., Gallagher, J. C., DeLuca, H. F., and Riggs, B. L., 1977, Intestinal calcium absorption in exogenous hypercorticism, J. Clin. Invest. 60: 253–259.CrossRefGoogle Scholar
  73. Knox, F. G., Osswald, H., Marchand, G. R., Spielman, W. S., Haas, J. A., Berndt, T., and Youngberg, S. P., 1977a, Phosphate transport along the nephron. Am. J. Physiol 233: F261–F268.PubMedGoogle Scholar
  74. Knox, F. G., Haas, J. A., Berndt, T., Marchand, G. R., and Youngberg, S. P., 1977b, Phosphate transport in superficial and deep nephrons in phosphate loaded rats. Am. J. Physiol 233: F150–F153.PubMedGoogle Scholar
  75. Kooh, S. W., Eraser, D., Toon, R., and DeLuca, H. F., 1976, Response of protracted neonatal hypocalcaemia to la,25–hydroxy-vitamin D3, Lancet 2: 1105–1107.PubMedCrossRefGoogle Scholar
  76. Kumar, R., and DeLuca, H. F., 1976, Side chain oxidation of 25–hydroxy-(26,27–14C)vitamin D3 and l,25–dihydroxy-(26,27–14C)vitamin D3 in vivo by chickens, Biochem. Biophys. Res. Commun. 69: 197–200.Google Scholar
  77. Kumar, R., and DeLuca, H. F., 1977, Side chain oxidation of 1,25–dihydroxy- vitamin D3 in the rat: Effect of removal of the intestine, Biochem. Biophys. Res. Commun. 76: 253–258.CrossRefGoogle Scholar
  78. Kumar, R., Harnden, D., and DeLuca, H. F., 1976, Metabolism of 1,25–dihydroxy- vitamin D3: Evidence for side-chain oxidation, Biochemistry 15: 2420–2422.Google Scholar
  79. Larsson, S. E., and Lorentzon, R., 1977, Excretion of active metabolites of vitamin D in urine and bile of the adult rat, Clin. Sei. Mol. Med. 53: 373–377.Google Scholar
  80. Lau, K., Agus, Z. S., Goldberg, M., and Goldfarb, S., 1977, Chronic phosphate depletion: Changes in segmental calcium and phosphate reabsorption, Kidney Int. 12: 458.Google Scholar
  81. Lee, S. W., Russell, J., and Avioli, L. V., 1977, 25–Hydroxycholecalciferol to 1,25–dihydroxycholecalciferol: Conversion impaired by systemic metabolic acidosis, Science 195: 994–996.Google Scholar
  82. Levin, M. E., Boisseau, V. C., and Avioli, L. V., 1976, Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes, N. Engl. J. Med. 294: 241–245.Google Scholar
  83. Lieberherr, M., Pezant, E., Garabedian, M., and Balsón, S., 1977, Phosphatase content of rat calvaría after in vivo administration of vitamin D3 metabolites, Calcif. Tissue Res. 23: 235–239.PubMedCrossRefGoogle Scholar
  84. Lim, P., Jacob, E., Tock, E. P. C., and Pwee, H. S., 1977, Calcium and phosphorus metabolism in nephrotic syndrome, Q. J. Med. 46: 327–338.Google Scholar
  85. Lindsay, R., Coutts, J. R. T., and Hart, D. M., 1977, The effect of endogenous estrogen on plasma and urinary calcium and phosphorus in oophorectom- ized women, Clin. Endocñnol. 6: 87–93.CrossRefGoogle Scholar
  86. Ljunghall, S., and Hedstrand, H., 1977, Serum phosphate inversely related to blood pressure, Br. Med. J. 1: 553–554.PubMedCrossRefGoogle Scholar
  87. Llach, F., Coburn, J. W., Brickman, A. S., Kurokawa, K., Norman, A. W., Canterbury, J. M., and Reiss, E., 1977, Acute actions of 1,25–dihydroxy- vitamin D3 in normal man: Effect on calcium and parathyroid status,J. Clin. EndocHnol. Metab. 44: 1054–1060.CrossRefGoogle Scholar
  88. Lumb, G. A., Mawer, E. B., and Stanbury, S., 1971, The apparent vitamin D resistance of chronic renal failure: A study of the physiology of vitamin D in mn, Am. J. Med. 50: 421–441.Google Scholar
  89. Matthews, C., Heimberg, K. W., Ritz, E., Agostini, B., Fritzsche, J., and Hassel- bach, W., 1977, Effect of 1,25–dihydroxycholecalciferol on impaired calcium transport by the sarcoplasmic reticulum in experimental uremia. Kidney Int. 11: 227–235.PubMedCrossRefGoogle Scholar
  90. Mawer, E. B., and Reeve, A., 1977, The use of an isolated perfused liver to study the control of cholecalciferol-25–hydroxylase activity in the rat, Calcif. Tissue Res. 22 (Suppl.): 24–28.Google Scholar
  91. Mawer, E. B., Lumb, G. A., Schaeffer, K., and Stanbury, S. W., 1971, The metabolism of isotopically labeled vitamin D3 in man: The influence of the state of vitamin D nutrition, Clin. Sei. 40: 39–53.Google Scholar
  92. Meema, H. E., and Meema, S., 1975, Improved roentgenologic diagnosis of osteomalacia by microradioscopy of hand bones. Am. J. Roentgenol. Radium Ther. Nucl. Med. 125: 925–935.Google Scholar
  93. Metz, S. A., Baylink, D. J., Hughes, M. R., Haussler, M. R., and Robertson, R. P., 1977, Selective deficiency of 1,25–dihydroxycholecalciferol: A cause of isolated skeletal resistance to parathyroid hormone, N. Engl. J. Med. 297: 1084–1090.Google Scholar
  94. Michalska, L., Wrobel, J., and Szczepanska-Konkel, M. S., 1976, The effect of calcium restriction in the diet on calcium transport in rat small intestine. Acta Biochim.Pol. 23: 109–114.PubMedGoogle Scholar
  95. Miravet, L., Redel, J., Carre, M., Queille, M. L., and Bordier, P., 1976, The biological activity of synthetic 25,26–dihydroxycholecalciferol and 24,25–dihy- droxycholecalciferol in vitamin D-deficient rats, Calcif. Tissue Res. 21: 145–152.PubMedCrossRefGoogle Scholar
  96. Mosekilde, L., Meisen, F., Christensen, M. S., Lund, B., and S0rensen, O. H., 1977, Effect of long-term vitamin D2 treatment on bone morphometry and biochemical values in anticonvulsant osteomalacia. Acta Med. Scand. 201: 303–307.PubMedCrossRefGoogle Scholar
  97. Mountokalakis, T. H., Virvidakis, C., Singhellakis, P., Alevizaki, C., and Ikkos, D., 1977, Intestinal calcium absorption in the nephrotic syndrome, Ann. Intern. Med. 86: 746–747.Google Scholar
  98. Muhlbauer, R. C., Bonjour, J. P., and Fleisch, H., 1977, Tubular localization of adaptation to dietary phosphate in rats. Am. J. Physiol. 233: F342–F348.PubMedGoogle Scholar
  99. Nassm, J. R., Saville, P. D., and Mulligan, L., 1956, The effect of stilbesterol on urinary phosphate excretion, Clin. Sei. 15: 367–371.Google Scholar
  100. Newman, J. H., Neff, T. A., and Ziporin, P., 1977, Acute respiratory failure associated with hypophosphatemia, N. Engl. J. Med. 296: 1101–1103.Google Scholar
  101. Nishii, Y., Kumaki, K., Fukushima, M., Shimizu, T., Ono, M., Okawa, H., Niki, R., Matsunaga, I., Ochi, K., Tohira, Y., Sasaki, S., and Suda, T., 1977, Metabolism of 25–hydroxy-vitamin D3 and 1 a-hydroxy-vitamin D3 in experimental rats with chronic renal failure, in: Vitamin D: Biochemical, Chemical and Clinical Aspects Related to Calcium Metabolism ( A. W. Norman, K. Schaefer, J. W. Coburn, H. F. DeLuca, D. Fraser, H. G. Grigoleit, and D. v. Herrath), pp. 179–181, Walter de Gruyter, Berlin and New York.Google Scholar
  102. O’Connor, L. R., Wheeler, W. S., and Bethune, J. E., 1978, Effect of hypophosphatemia on myocardial performance in man (letter), N. Engl. J. Med. 298: 341.Google Scholar
  103. O’Connor, P., 1977, Vitamin D-deficiency rickets in two breast-fed infants who were not receiving vitamin D supplementation, Clin. Pediatr. 16: 361–363.Google Scholar
  104. Omdahl, J. L., and Evan, A. P., 1977, Kidney mitochondria metabolism of 25–hydroxy-vitamin D3: Evaluation of in vitro cation modulation. Arch. Biochem. Biophys. 184: 179–188.CrossRefGoogle Scholar
  105. Peacock, M. (ed.), 1977, The clinical uses of la-hydroxyvitamin D3, Clin. Endocrinol. 7(Suppl.).Google Scholar
  106. Pento, J. T., Waite, L. C., Tracy, P. J., and Kenney, A. D., 1977, Adaptation to calcium deprivation in the rat: Effects of parathyroidectomy, Am. J. Physiol. 232: E336–E342.PubMedGoogle Scholar
  107. Pierides, A. M., Ward, M. K., Alvarez-Ude, F., Ellis, H. A., Peart, K. M., Simpson, W., Kerr, D. N. S., and Norman, A. W., 1976, Long term therapy with 1,25(0H)2D3 in dialysis bone disease, Proc. Eur. Dial. Transplant Assoc. 12: 237–244.Google Scholar
  108. Piérides, A. M., Ellis, H. A., Ward, M. K., Simpson, W., and Kerr, D. N. S., 1977, la-Hydroxycholecalciferol in renal osteodystrophy, Calcif. Tissue Res. 22(SuppL): 105–111.Google Scholar
  109. Pike, J. W., Toverud, S., Boass, A., McCain, T., and Haussler, M. R., 1977, Circulating la,25–(OH)2D during physiological states of calcium stress, in: Vitamin D: Biochemical, Chemical and Clinical Aspects Related to Calcium Metabolism ( A. W. Norman, K. Schaefer, J. W. Coburn, H. F. DeLuca, D. Fraser, H. G. Grigoleit, and D. v. Herrath, eds.), pp. 187–189, Walter de Gruyter, Berlin and New York.Google Scholar
  110. Popovtzer, M. M., and Robinette, J. B., 1975, Effect of 25(OH)-vitamin D3 on urinary excretion of cyclic adenosine monophosphate. Am. J. Physiol. 229: 907–910.Google Scholar
  111. Popovtzer, M. M., Blum, M. S., and Flis, R. S., 1977, Evidence for interference of 25(OH)-vitamin Dg with phosphaturic action of calcitonin. Am. J. Physiol. 232: E515–E521.PubMedGoogle Scholar
  112. Puschett, J. B., Moranz, J., and Kurnick, W. S., 1972, Evidence for a direct action of cholecalciferol and 25–hydroxycholecalciferol on the renal transport of phosphate, sodium and calcium,J. Clin. Invest. 51: 373–388.CrossRefGoogle Scholar
  113. Puschett, J. B., Beck, W. S., and Jelonek, A., 1975, Parathyroid hormone and 25–hydroxy-vitamin D3: Synergistic and antagonistic effects on renal phosphate transport. Science 190: 473–475.Google Scholar
  114. Rasmussen, H., Wong, M., Bikle, D., and Goodman, D. B. P., 1972, Hormonal control of the renal conversion of 25–hydroxycholecalciferol to 1,25–dihy- droxycholecalciferol,J. Clin. Invest. 51: 2502–2504.CrossRefGoogle Scholar
  115. Rizzoli, R., Fleisch, H., and Bonjour, J. P., 1977, Role of 1,25–dihydroxy-vitamin D3 on intestinal phosphate absorption in rats with a normal vitamin D supply, J. Clin. Invest. 60: 639–647.CrossRefGoogle Scholar
  116. Roelofs, J. M. M., and Raymakers, J. A., 1976, Calculation of three hour calcium absorption from a double isotope test: A simplified method, Clin. Chim. Acta 67: 53–62.CrossRefGoogle Scholar
  117. Rosen, J. F., Fleischman, A. R., Einberg, L., Eisman, J., and DeLuca, H. F., 1977, 1,25–Dihydroxycholecalciferol: Its use in the long-term management of idiopathic hypoparathyroidism in children, J. Clin. Endocrinol. Metab. 45: 457–468.CrossRefGoogle Scholar
  118. Rutherford, W. E., Bordier, P., Marie, P., Hruska, K., Harter, H., Greenwalt, A., Blondin, J., Haddad, J., Bricker, N., and Slatopolsky, E., 1977, Phosphate control and 25–hydroxycholecalciferol administration in preventing experimental renai osteodystrophy in the dog, J. Clin. Invest. 60: 332–341.CrossRefGoogle Scholar
  119. Sauveur, B., Garabedian, M., Fellot, C., Mongin, P., and Balsan, S., 1977, The effect of induced metabolic acidosis on vitamin D3 metabolism in rachitic chicks, Calcif. Tissue Res. 23: 121–124.PubMedCrossRefGoogle Scholar
  120. Schmidt-Gayk, H., Schmitt, W., Grawunder, L., Ritz, E., Tschöpe, W., Pietsch, V., Andrassy, K., and Bouillon, R., 1977, 25–Hydroxy-vitamin D in nephrotic syndrome. Lancet 2: 105–108.Google Scholar
  121. Schneider, L. E., Schedl, H. P., McCain, T., and Haussler, M. R., 1977, Experimental diabetes reduces circulating 1,25–dihydroxy-vitamin D in the rat. Science 196: 1452–1454.PubMedCrossRefGoogle Scholar
  122. Schoenfeld, P., Martin, J. H., Barnes, B., and Teitelbaum, S. L., 1977, Amelioration of myopathy with 25–hydroxy-vitamin Dg therapy in patients on chronic hemodialysis. Abstract Book, p. 160 ( Third Workshop on Vitamin D, Asilomar, California ).Google Scholar
  123. Searles, R. P., Bankhurst, A. D., Ahlin, T. D., and Messner, R. P., 1977, Antacid induced hypophosphatemia: An unusual case of pseudomyopathy, J. Rheumatol 4: 176–178.Google Scholar
  124. Shikita, M., Tsurufuji, S., and Ito, Y., 1962, Adaptation in renal phosphorus excretion under the influence of parathyroids: A study in unilaterally cathe- terized ra ts, Endocrinol. Jpn. 9: 171.Google Scholar
  125. Sinha, T. K., DeLuca, H. F., and BeU, N. H., 1977, Evidence for a defect in the formation of la:,25–dihydroxy-vitamin D in pseudohypoparathyroidism, Metabolism 26: 731–738.PubMedCrossRefGoogle Scholar
  126. Skinner, R. K., Sherlock, S., Long, R. G., and Wills, M. R., 1977, 25–Hydroxylation of vitamin D in primary biliary cirrhosis, Lancet 1: 720–721.Google Scholar
  127. Steele, T. H., 1976, Renal resistance to parathyroid hormone during phosphorus deprivation,J. Clin. Invest. 58: 1461–1464.CrossRefGoogle Scholar
  128. Steele, T. H., 1977, Renal response to phosphorus deprivation: Effect of the parathyroids and bicarbonate. Kidney Int. 11: 327–334.Google Scholar
  129. Steele, T. H., and DeLuca, H. F., 1976, Influence of dietary phosphorus on renal phosphate reabsorption in the parathyroidectomized rat, J. Clin. Invest. 57: 867–874.CrossRefGoogle Scholar
  130. Swenson, R. S., Weisinger, J. R., Ruggeri, J. L., and Reaven, G. M., 1975, Evidence that parathyroid hormone is not required for phosphate homeostasis in renal failure. Metabolism 24: 199–204.PubMedCrossRefGoogle Scholar
  131. Tanaka, Y., Castillo, L., and DeLuca, H. F., 1976, Control of renal vitamin D hydroxylase in birds by sex hormones, Proc. Natl. Acad. Sei. U.S.A. 73: 2701–2705.CrossRefGoogle Scholar
  132. Taylor, C. M., 1977, The measurement of 24,25–dihydroxycholecalciferol in human serum, in: Vitamin D: Biochemical, Chemical and Clinical Aspects Related to Calcium Metabolism ( A. W. Norman, K. Schaefer, J. W. Coburn, H. F. DeLuca, D. Eraser, H. G. Grigoleit, and D. v. Herrath), pp. 541–543, Walter de Gruyter, Berlin and New York.Google Scholar
  133. Taylor, C. M., DeSilva, P., and Hughes, S. E., 1977, Competitive protein-binding assay for 24,25–dihydroxycholecalciferol, Calcif. Tissue Res. 22 (SuppL): 40–44.Google Scholar
  134. Tröhler, U., Bonjour, J. P., and Fleisch, H., 1976a, Renal tubular adaptation to dietary phosphorus, Nature (London) 261: 145–146.CrossRefGoogle Scholar
  135. Tröhler, U., Bonjour, J. P., and Fleisch, H., 1976b, Inorganic phosphate homeostasis, renal adaptation to the dietary intake in intact and thyroparathyroidec- tomized rats, J. Clin. Invest. 57: 264–273.CrossRefGoogle Scholar
  136. Turner, T. L., Cockburn, F., and Forfar, J. D., 1977, Magnesium therapy in neonatal tetany, Lancet 1: 283–284.PubMedCrossRefGoogle Scholar
  137. Van Stone, J. C., Frank, D. E., and Bradford, W. R., 1977, The effect of decreased renal function with and without reduction in renal mass on 1,25–dihydroxy- cholecalciferol production in rats,J. Lab. Clin. Med. 89: 1168–1174.Google Scholar
  138. Walker, D. A., 1977, Control of renal tubular phosphate reabsorption by parathyroid hormone in man, Clin. Sei. Mol. Med. 53: 431–438.Google Scholar
  139. Walling, M. W., 1977, Intestinal Ca and phosphate transport: Differential responses to vitamin D3 metabolites, Am. J. Physiol. 233: E488–E494.PubMedGoogle Scholar
  140. Walling, M. W., Hartenbower, D. L., Coburn, J. W., and Norman, A. W., 1977, Effects of la,25–, 24R,25–and la,24R,25–hydroxylated metabolites of vitamin D3 on calcium and phosphate absorption by duodenum from intact and nephrectomized rats. Arch. Biochem. Biophys. 182: 251–257.CrossRefGoogle Scholar
  141. Weber, H. P., Gray, R. W., Dominguez, J. H., and Lemann, J., Jr., 1976, The lack of effect of chronic metabolic acidosis on 25–OH-vitamin D metabolism and serum parathyroid hormone in humans,J. Clin. Endocrinol. Metab. 43: 1047–1055.Google Scholar
  142. Westby, G. R., Goldfarb, S., Goldberg, M., and Agus, Z. S., 1977, Acute effects of bovine growth hormone in renal calcium and phosphorus excretion, Metabolism 26: 525–530.PubMedCrossRefGoogle Scholar
  143. Witmer, G., Margolis, A., Fontaine, O., Fritsch, J., Lenoir, G., Broyer, M., and Balsan, S., 1976, Effects of 25–hydroxycholecalciferol on bone lesions of children with terminal renal failure. Kidney Int. 10: 395–408.PubMedCrossRefGoogle Scholar
  144. Wyman, A. L., Paradinas, F. J., and Daly, J. R., 1977, Hypophosphataemic osteomalacia associated with a malignant tumour of the tibia: Report of a J.Clin. Pathol. 30: 328–335.CrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1979

Authors and Affiliations

  • Jack W. Coburn
    • 1
  • Kiyoshi Kurokawa
    • 1
  • Charles R. Kleeman
    • 2
  1. 1.Nephrology Section, Medical and Research Services, Veterans Administration Wadsworth Hospital Center and Department of MedicineUniversity of California at Los Angeles School of MedicineLos AngelesUSA
  2. 2.Center for Health, Enhancement, Education, and Research, Department of MedicineUniversity of California at Los Angeles School of MedicineLos AngelesUSA

Personalised recommendations